Business Context and Reporting Period
This Form 8-K filing by iSpecimen Inc. (ISPC) is dated June 4, 2025. The report addresses a regulatory notice received from The Nasdaq Stock Market LLC regarding the company's compliance with continued listing standards.
Key Financial Metrics
The filing references specific financial data from the company's most recent Quarterly Report on Form 10-Q for the period ended March 31, 2025:
- Stockholders' Equity: $1,668,513
- Nasdaq Minimum Equity Requirement: $2.5 million
- Net Income/Market Value: The filing states the company does not meet alternative criteria related to market value of listed securities or net income from continuing operations, but does not provide specific figures for these metrics.
Material Changes and Events
On June 4, 2025, iSpecimen Inc. received a notification from Nasdaq stating it no longer complies with Listing Rule 5550(b)(1) due to insufficient stockholders' equity. The company's equity of approximately $1.67 million falls below the required $2.5 million threshold. Additionally, the company fails to meet alternative listing criteria based on market value or net income.
Outlook, Risks, and Management Commentary
Compliance Plan: The company intends to submit a plan to regain compliance within the 45-calendar-day window provided by Nasdaq rules. If accepted, the company may receive an extension of up to 180 calendar days to demonstrate compliance.
Risks and Contingencies: Management explicitly states there is no assurance that Nasdaq will accept the proposed plan or that the company will regain compliance within the applicable period. If the plan is rejected, the company retains the right to appeal the determination to a Nasdaq Hearings Panel.
Trading Status: The notification has no immediate effect on the listing or trading of the company's common stock, which continues to trade on the Nasdaq Capital Market under the symbol "ISPC."
Investor Verification Checklist
- Verify the specific details of the compliance plan once submitted by the company.
- Monitor the 45-day deadline for plan submission and the subsequent 180-day compliance period.
- Review the Form 10-Q for the period ended March 31, 2025, to analyze the full financial context of the equity shortfall.
- Watch for any updates regarding the acceptance or rejection of the compliance plan by Nasdaq.